Advancing Diabetes Care: Role of Biomarkers in Diagnosis, Management, and Prognosis

Read full text Summarise with VIRAT
Authors: Sandhya Baranwal
Cited by: 0
References: 83

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Biomarkers play a crucial role in advancing diabetes care in terms of diagnosis, management, and prognosis. In diagnosis, traditional markers, such as fasting glucose and HbA1c, are complemented by emerging biomarkers, such as specific amino acid profiles and IgG glycosylation patterns, which may enable earlier detection. Glycemic control biomarkers, indicators of diabetes complications, and pharmacogenomic markers allow for more personalized treatment approaches for disease management. Prognostic biomarkers of cardiovascular risk, renal function, and disease progression can help predict outcomes and guide interventions. Novel technologies, such as continuous glucose monitoring and artificial intelligence, have enhanced biomarker detection and analysis. However, challenges remain in the standardization, accessibility, and clinical application of biomarkers. Future research directions include multi-omics approaches and microbiome-based markers. As biomarker use expands, ethical considerations regarding privacy, equitable access, and psychological impacts must be addressed. Biomarkers are transforming diabetes care into more precise, personalized, and predictive approaches.

Fields of Study & Subjects

Diabetes Management and Research Diabetes Cardiovascular Risks and Lipoproteins Diabetes and associated disorders

Publication details

Journal / source
International Journal of Pharmacology and Clinical Research
Volume
8
Issue
2
Pages
55–63
Publication date
1 February 2026
Language
EN